Cover Image
市場調查報告書

全球針對醫療的處方的分析市場:成長,趨勢,預測(2017年∼2022年)

Global Healthcare Prescriptive Analytics Market Growth, Trends & Forecast (2017 - 2022)

出版商 Mordor Intelligence LLP 商品編碼 353812
出版日期 內容資訊 英文 185 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球針對醫療的處方的分析市場:成長,趨勢,預測(2017年∼2022年) Global Healthcare Prescriptive Analytics Market Growth, Trends & Forecast (2017 - 2022)
出版日期: 2017年01月24日 內容資訊: 英文 185 Pages
簡介

醫療處方分析,不僅預測未來,基於預測其次揭示應採取動作合理化決策流程。技術進步,及醫療的巨量資料的整合,醫療費削減及效率提高的必要性等成為這個市場的主要促進成長因素。

本報告提供全球醫療處方分析市場相關調查,市場概要,各應用、零組件、引進模式、終端用戶、地區的市場趨勢,市場規模的變化與預測,市場成長、阻礙因素以及市場機會分析,市場佔有率,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 市場定義
  • 單位
  • 基本貨幣
  • 預測期間
  • 調查的前提條件
  • 報告概要

第2章 調查方法

  • 簡介
  • 調查手法
  • 計量預測模式
  • 調查的前提條件

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要與產業趨勢

  • 目前市場方案
  • 技術概要
  • 新的開發
  • 投資分析
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 市場動態

  • 市場成長要素
    • 技術的進步
    • 醫療的巨量資料的整合
    • 效率提高及降低成本的必要性
  • 市場阻礙因素
    • 高的初期投資成本
    • 醫療領域的IT專家的不足
    • 資料安全與隱私相關疑慮
    • 醫療提供者對與第三者共有資料的抗拒感
  • 市場機會
    • 醫療IT的擴大
    • 新興經濟國的醫療重要性的提高
  • 主要課題
    • 資料保存、管理、安全的課題

第7章 全球醫療的處方分析市場:市場區隔

  • 各應用領域
    • 臨床資料分析
    • 財務資料分析
    • 管理資料分析
    • 研究資料分析
  • 各零件
    • 軟體
    • 硬體設備
    • 服務
  • 各引進模式
    • 內部部署
    • Web基礎
    • 雲端基礎
  • 各終端用戶
    • 民營企業
    • 政府機關
    • 研究機關

第8章 全球醫療處方的分析市場:各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙、葡萄牙
    • 義大利
    • 北歐各國
    • 荷比盧三國
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 中東、北非
    • 波灣合作理事會(GCC)
    • 埃及
    • 蘇丹
    • 摩洛哥
    • 阿爾及利亞
  • 南美
    • 阿根廷
    • 巴西
    • 智利

第9章 競爭情形

  • 合併、收購
  • 新產品的銷售
  • 協定、合作、夥伴關係

第10章 主要供應商

  • IBM
  • Cerner
  • Oracle
  • McKesson corporation
  • Medeanalytics, Inc.
  • Optum, Inc.
  • Allscripts Healthcare Solutions Inc.
  • Truven Healthanalytics, Inc.
  • Verisk Analytics
  • SAS institute Inc.

第11章 分析師對投資機會的見解

第12章 市場未來展望

第13章 附錄

  • 簡稱
  • 參考文獻
  • 免責聲明

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The global healthcare prescriptive analytics market is estimated to be USD XX billion in 2016 and is projected to reach USD XX billion by 2021, at a CAGR of XX% during the forecast period from 2016 to 2021.

Prescriptive analytics is the final stage as well as the future of healthcare analytics. It goes beyond predicting future outcomes to suggest alternative options at hand and then demonstrates the implication of each option to make the decision-making process more rational, streamlined, and optimized.

Global Healthcare Prescriptive Analytics Market-Market Dynamics

To predict the future, we need data from the past as well as the present and the present never stops generating data, and analyzing the data being generated at the same time makes this process complex and machine-intensive. Adding more complexity to it is the nature of data, which is not the traditional data what we are used to handling but includes audio, videos, and images of different sizes and quality. Hence, predicting the future and then suggesting alternative options along with the implication of each option requires advanced technology, computing system, and better techniques.

Drivers:

Some of the drivers of this market are:

  • Recent advancements in technology
  • Integration of big data in healthcare
  • Need to curtail healthcare cost
  • Need to increase efficiency

Restraints:

The technology has certain constraints to overcome. These include:

  • High cost of initial investments
  • Lack of properly trained IT professionals in healthcare
  • Healthcare providers' reluctance to share data with the third party (analytics firm)
  • Data integrity and safety concerns

Opportunities:

The technology has several opportunities as well. These include:

  • Introduction and implementation of Electronic Health Records (HER)
  • Rising investments in venture capital funds
  • Implementation of trends in the medical-IT field, such as precision medicines, HER, analytics-driven personalized medicines, clinical DSS, health and disease management, and so on.

The global healthcare prescriptive analytics market is segmented on the basis of application (clinical data analytics, financial data analytics, administrative data analytics, and research data analytics), component (software, hardware, and services), deployment (on-premise model and cloud-based model), end-user (private organization (hospitals, clinics, physicians), government organization and research institutions), and geography (North America, Europe, Asia-Pacific, Middle East & Africa and Latin America).

Currently, the descriptive analytics segment accounts for the largest market share of 62% in the global healthcare technology but its share is expected to decrease and predictive analytics is expected to gain some ground in the near future. In the long run, prescriptive analytics is going to gain ground and is expected to see rapid growth. By application, the clinical analytics segment is forecasted to have the highest growth rate. Although the market growth of the cloud-based services segment is increasing substantially, the on-premise delivery system segment still accounts for the largest share due to its multi-vendor framework. This kind of architecture usually ensures the safety of data and transactions from attacks.

The primary stakeholders of this technology are healthcare IT firms, healthcare analytics vendors, care organizations, health insurance providers, healthcare payers, healthcare providers, research firms, consultants, ambulatory services, and venture capitalists.

Some of the key players in the market are:

  • Allscripts Healthcare Solutions Inc.
  • Cerner
  • IBM
  • McKesson corporation
  • Medeanalytics, Inc.
  • Optum, Inc.
  • Oracle

Key Deliverables in the Study:

  • Market analysis for the healthcare prescriptive analytics market, with region-specific assessments and competition analysis on the global and regional scale.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market share.
  • Identification and analysis of the macro and micro factors that affect the global healthcare prescriptive analytics market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.

Table of Contents

1. Introduction

  • 1.1. Study deliverables
  • 1.2. Market Definition
  • 1.3. Sizing Units
  • 1.4. Base Currency
  • 1.5. Review and forecast period years
  • 1.6. General Study Assumptions
  • 1.7 Report Description

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Analysis Methodology
  • 2.3. Econometric forecast models
  • 2.4. Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Overview & Industry Trends

  • 5.1. Current market scenario
  • 5.2. Technology Overview
  • 5.3. New developments
  • 5.4. Investment analysis
  • 5.5. Porters Five Force Analysis
    • 5.5.1 Bargaining Power of suppliers
    • 5.5.2 Bargaining power of buyers
    • 5.5.3 Degree of competition
    • 5.5.4 Threat of substitution
    • 5.5.5 Threat of new entrants

6. Drivers, Restraints, Opportunities & Challenges Analysis (DROC)

  • 6.1. Market Drivers
    • 6.1.1 Technological advancements
    • 6.1.2 Integration of big data in healthcare
    • 6.1.3 Growing need of increasing efficiency and cutting cost at the same time
  • 6.2. Market Restraints
    • 6.2.1 High cost of initial investment
    • 6.2.2 Lack of properly trained IT professionals in healthcare
    • 6.2.3 Data security and privacy concerns
    • 6.2.4 Healthcare providers' reluctance to share data with the third party (analytics firm)
  • 6.3 Market Opportunities
    • 6.3.1 Expansion of healthcare IT
    • 6.3.2 Emerging economies and growing importance of healthcare in these countries
  • 6.4. Key Challenges
    • 6.4.1 Data storage, maintenance, and security

7. Global Healthcare Prescriptive Analytics Market Segmentation

  • 7.1 By Application
    • 7.1.1 Clinical Data Analytics
    • 7.1.2 Financial Data Analytics
    • 7.1.3 Administrative Data Analytics
    • 7.1.4 Research Data Analytics
  • 7.2 By Component
    • 7.2.1 Software
    • 7.2.2 Hardware
    • 7.2.3 Services
  • 7.3 By Deployment
    • 7.3.1 On-Premise
    • 7.3.2 Web- based
    • 7.3.3 Cloud based
  • 7.4 By End-User
    • 7.4.1 Private organization
      • 7.4.1.1 Hospitals
      • 7.4.1.2 Physicians
      • 7.4.1.3 Clinics
    • 7.4.2 Government organization
    • 7.4.4 Research institution

8. Global Healthcare Prescriptive Analytics Market by Geography - Regional shares and forecast

  • 8.1 North America
    • 8.1.1 USA
    • 8.1.2 Canada
    • 8.1.3 Mexico
  • 8.2 Europe
    • 8.2.1 UK
    • 8.2.2 Germany
    • 8.2.3 France
    • 8.2.4 Spain & Portugal
    • 8.2.5 Italy
    • 8.2.6 Scandinavia
    • 8.2.7 Benelux
  • 8.3 Asia-Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 India
    • 8.3.4 South Korea
    • 8.3.5 Australia
  • 8.4. Middle East and North Africa (MENA)
    • 8.4.1 GCC
    • 8.4.2. Egypt
    • 8.4.3. Sudan
    • 8.4.4. Morocco
    • 8.4.5. Algeria
  • 8.5. Latin America
    • 8.5.1Argentina
    • 8.5.2. Brazil
    • 8.5.3. Chile

9. Competitive Landscape

  • 9.1 Mergers & Acquisitions
  • 9.2 New Product Launches
  • 9.3 Agreements, Collaborations & Partnerships

10. Key Vendors

  • 10.1 IBM
  • 10.2 Cerner
  • 10.3 Oracle
  • 10.4 McKesson corporation
  • 10.5 Medeanalytics, Inc.
  • 10.6 Optum, Inc.
  • 10.7 Allscripts Healthcare Solutions Inc.
  • 10.8 Truven Healthanalytics, Inc.
  • 10.9 Verisk Analytics
  • 10.10 SAS institute Inc.

11. Analyst outlook for Investment Opportunities

12. Future outlook of the market

13. Appendix

  • 13.1 Abbreviations
  • 13.2 Bibliography
  • 13.3 Disclaimer
Back to Top